AU2001241610A1 - Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies - Google Patents

Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies

Info

Publication number
AU2001241610A1
AU2001241610A1 AU2001241610A AU4161001A AU2001241610A1 AU 2001241610 A1 AU2001241610 A1 AU 2001241610A1 AU 2001241610 A AU2001241610 A AU 2001241610A AU 4161001 A AU4161001 A AU 4161001A AU 2001241610 A1 AU2001241610 A1 AU 2001241610A1
Authority
AU
Australia
Prior art keywords
polypeptides
antibodies
protein tyrosine
tyrosine phosphatase
phosphatase polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241610A
Inventor
Steven M Ruben
Yanggu Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001241610A1 publication Critical patent/AU2001241610A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
AU2001241610A 2000-03-03 2001-02-22 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies Abandoned AU2001241610A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18665800P 2000-03-03 2000-03-03
US60186658 2000-03-03
US18988100P 2000-03-16 2000-03-16
US60189881 2000-03-16
PCT/US2001/005496 WO2001066706A1 (en) 2000-03-03 2001-02-22 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies

Publications (1)

Publication Number Publication Date
AU2001241610A1 true AU2001241610A1 (en) 2001-09-17

Family

ID=26882299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241610A Abandoned AU2001241610A1 (en) 2000-03-03 2001-02-22 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies

Country Status (6)

Country Link
US (1) US20030175934A1 (en)
EP (1) EP1263940A4 (en)
JP (1) JP2003525628A (en)
AU (1) AU2001241610A1 (en)
CA (1) CA2399921A1 (en)
WO (1) WO2001066706A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511660A (en) * 2001-12-04 2005-04-28 デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング PTP10D, Tec protein tyrosine kinase and EDTP homologous proteins involved in the regulation of energy homeostasis
AU2003227071A1 (en) * 2002-03-14 2003-09-22 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
WO2003103704A2 (en) * 2002-06-10 2003-12-18 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
WO2004054601A2 (en) * 2002-12-16 2004-07-01 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Fwd, pp2c1, adk3, cg3860, cdk4, cg7134, eip75b involved in the regulation of energy homeostasis
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
MXPA06004199A (en) * 2003-10-17 2006-06-28 Novo Nordisk As Combination therapy.
EP1703279A4 (en) * 2003-12-19 2007-12-26 Nec Corp Method of identifying protein with the use of mass spectrometry

Also Published As

Publication number Publication date
EP1263940A1 (en) 2002-12-11
CA2399921A1 (en) 2001-09-13
WO2001066706A1 (en) 2001-09-13
EP1263940A4 (en) 2004-08-11
JP2003525628A (en) 2003-09-02
US20030175934A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2001233156A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
AU2001271714A1 (en) B7-like polynucleotides, polypeptides, and antibodies
WO2002002636A3 (en) Membrane associated protein zupari
AU3075801A (en) Transferrin polynucleotides, polypeptides, and antibodies
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU2001232833A1 (en) Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU2001253323A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU7829700A (en) Protein phosphatase and kinase proteins
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
AU2001241610A1 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU8010000A (en) Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001241611A1 (en) Adam polynucleotides, polypeptides, and antibodies
AU2002351469A1 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
AU5137698A (en) Novel dna, novel protein, and novel antibody
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001247306A1 (en) Immune system-related polynucleotides, polypeptides, and antibodies
EP1212415A4 (en) Pgrp-l polynucleotides, polypeptides, and antibodies
AU2001245354A1 (en) Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
AU2001262925A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001249898A1 (en) Tm4sf receptor polynucleotides, polypeptides, and antibodies
AU1758001A (en) Kringle domain-containing polynucleotides, polypeptides, and antibodies
AU2001229508A1 (en) Nucleic acids, proteins, and antibodies
AU2001249356A1 (en) Bone morphogenic protein polynucleotides, polypeptides, and antibodies